The benefits and drawbacks of biosimilars.

Tele-rehabilitation the benefits and drawbacks

The Covid-19 pandemic has impacted negatively on our society and resulted in numerous deaths. It had an effect on every facet of health-care delivery. Rules, regulations, and payment policies were changed to allow extensive use of telecommunications technology in lieu of in-person clinical visits to protect health care personnel and patients throughout the country from the risk of disease trans...

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

OBJECTIVE To understand the levels of awareness, usage, and knowledge of biosimilars among patients, caregivers, and the general population in the US and the European Union; perceptions of biosimilars compared to originator biologics; perceived benefits and drawbacks of clinical trials; and whether advocacy groups impact patients' willingness to try a biosimilar. METHODS An international surv...

Are Biosimilars Identical to the Reference Products?

The economics of biosimilars.

BACKGROUND The high cost of pharmaceuticals, especially biologics, has become an important issue in the battle to control healthcare costs. The Hatch-Waxman Act encourages generic competition but still provides incentives for pioneers to develop new drugs. The Biologics Price Competition and Innovation Act is intended to do the same for biologics and biosimilars. OBJECTIVE To examine informat...

Are Biosimilars Identical to the Reference Products?